SEREX

SEREX = Serological Analysis of Recombinant cDNA (Complementary Deoxyribonucleic Acid) Expression Libraries

SEREX first developed in 1995 see Human neoplasms elicit multiple specific immune responses in the autologous host. paper

SEREX paper performance of protein microarrays using SEREX derived antigens paper

SEREX review papers

Identification of human tumor antigens by serological expression cloning c an online review on SEREX

The reverse proteomics for identification of tumor antigens. Pusan National University in Busan Korea 2007 This article can't be found (the links to it are to the wrong article)

Potential target antigens for immunotherapy identified by serological expression cloning (SEREX). Dirk Jager 2007 Germany

Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning. Cancer Immunology, Immunotherapy 2003 Greece

Serum autoantibodies as biomarkers for early cancer detection. paper

High throughput proteomic strategies for identifying tumour-associated antigens. paper

Identification of tumour antigens by serological analysis of cDNA expression cloning. paper

Mapping the high throughput SEREX technology screening for novel tumor antigens. Combinatorial Chemistry & High Throughput Screening. 2012 from Chengdu Sichuan China This article is behind a paywall

Identifying autoantibody signatures in cancer: a promising challenge.

Desmetz C, Maudelonde T, Mangé A, Solassol J.

Expert Rev Proteomics. 2009 Aug;6(4):377-86. doi: 10.1586/epr.09.56. Review. CHU Montpellier, Laboratoire de Biologie Cellulaire et Hormonale, Hôpital Arnaud de Villeneuve, 371 Avenue du Doyen Giraud, Montpellier, F-34295, France. article is behind a paywall

This article looks quite good and interesting and has some nice figures. The current status of cancer biomarker research using tumour-associated antigens for minimal invasive and early cancer diagnostics

http://www.sciencedirect .com/science/article/pii/S1874391912005520 or "C:\kurt\storage\CIM Research Folder\DR\2013\2-18-13\SEREX paper\The current status of cancer biomarker research using tumour-associated antigens for minimal invasive and early cancer diagnostics.pdf"